Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Lifestyle Natural Medicines

Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations

TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group” or the “Company“) (CSE: PSYG) hereby announces that it has entered into an addendum to the previously announced debt-for-equity swap agreements (the “Debt Swap Agreem

By: Financial Post

Dec 21 2024
70
13143 Views

Author of the article:
Article content
TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) Psyence Group Inc (Psyence Group or the Company) (CSE: PSYG) hereby announces that it has entered into an addendum to … [+10351 chars]

Related

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Genentech's Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson's Disease

Europe Dental Bone Grafts And Substitutes Market to Set to Surpass Valuation of US$ 494.18 Million By 2032 | Astute Analytica

Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations

Major mistake people make to get yellow teeth even if they brush them twice a day

Connor Clark & Lunn Investment Management Ltd. Acquires 34,599 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Brokerages Set Nektar Therapeutics (NASDAQ:NKTR) Target Price at $3.50

Analysts Issue Forecasts for NKTR Q1 Earnings

Research Analysts Offer Predictions for NKTR FY2024 Earnings

Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma

Contrasting Aravive (NASDAQ:ARAV) and Nektar Therapeutics (NASDAQ:NKTR)

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting